
ClinVar
5
MENTIONS
4
EPISODES
4
PODCASTS
Search complete. 5 mentions across 4 episodes found for "ClinVar".
Sep 7, 2026
455: Agentic genomics: the bottleneck moves from code to judgment
S
5:56speaker_2HOST
Right.
S
5:57speaker_2HOST
It selects FASPRP, BWA-MM2, JDK haplotype caller, deep variant, and sense in PF with ClinVar.
S
6:04speaker_1HOST
Yeah.
S
6:05speaker_1HOST
And here is where the magic moment happens in the example.
How to Identify the Blind Spots in Your Biotech's Genomic Data Before They Cost You a Drug Target
E
45:40Erika KvikstadGUEST
So now we're going to say, well, is it having a consequence? And is that consequence important to disease? So there are a lot of algorithms now that are predicting what is the impact on clinical data.
E
45:53Erika KvikstadGUEST
And we have resources like ClinVar, we have ClinGen and the process of having the clinician involved through that vetting stage.
E
46:04Erika KvikstadGUEST
And we have some guidelines that we use to say that this is statistically associated and likely to be pathogenic, likely pathogenic, other categories.
E
46:15Erika KvikstadGUEST
And that includes variants of unknown significance.
Episode: 45 - Ben Busby on Genomics at GPU Speed
E
9:19Eleanor HoweHOST
Yeah.
B
9:19Ben BusbyGUEST
And you could see, you know, what your background looks like in the context of 1000 Genomes, and then you could al- take all the SNPs that you have in ClinVar and see, you know, how those SNPs are contextualized, et cetera, et cetera.
E
9:33Eleanor HoweHOST
Oh, okay.
B
9:33Ben BusbyGUEST
So that would be, you know, that's something that you could do that, that might be interesting.
7 MINS LATER
E
16:56Eleanor HoweHOST
W- where do you, where do you see it happening that access to better tools is not translating into better outcomes?
B
17:02Ben BusbyGUEST
Oh, that's a great question, and I think the answer is, and this is almost an old adage, but when people use fancier and fancier tools to ask the same questions they've been asking for a long time.
B
17:18Ben BusbyGUEST
And I think really that happens when people fail to do the work to contextualize biology, right? If you have a particular SNP in ClinVar, and that there's a penetrance measured in, you know, a particular population, you know, in, in Germany or the United States or something like that- One thing that has been very clear, particularly with papers just in the last few months, is that may not be the same level of penetrance, you may not get the same presentation with folks that are in Pakistan, for example, at least on a sort of social, societal level.
B
17:54Ben BusbyGUEST
And then I would say that, you know, we, we often completely ignore, you know, things that have, you know, two, three, four, five genomic loci that are really, you know, important in, you know, manifestation and presentation of disease.
Design Above the Interface with Justin Ranton
K
5:34Kelly SmithHOST
Mm.
J
5:34Justin RantonGUEST
Um, so it works with like ClinVar, PubMed, it pulls in all these different sources of data, and it creates basically evidence for a particular, uh, situation that you may have.
J
5:47Justin RantonGUEST
Let's say you have, uh, ADHD like I do.
J
5:49Justin RantonGUEST
Um, it may say, "These are all the things that could be impacting your ADHD.